抗菌医療用テキスタイル市場：地域別、2024年～2031年

抗菌医療用テキスタイル市場評価、2024年～2031年

ヘルスケア負担の増加や感染予防・管理の重視の高まりが、抗菌医療用テキスタイルの需要を押し上げています。ヘルスケア費用の増加に伴い、医療関連感染（HAI）を減らすための効果的で費用対効果の高いソリューションに対する需要が高まっています。抗菌テキスタイルは、危険な感染症の蔓延を防ぎ、患者の転帰を改善し、医療費を削減するための実行可能な戦略です。市場規模は2024年に155億1,000万米ドルを超え、2031年には約260億7,000万米ドルに達します。

抗生物質耐性の頻度の増加は、公衆衛生に大きな脅威をもたらします。抗菌テキスタイルは、抗生物質を使用しない感染制御の代替方法を提供することで、抗生物質耐性に対処するのに役立ちます。医療用テキスタイルに抗菌性を付加することで、ヘルスケア機関はより衛生的な雰囲気を提供し、抗生物質への依存を減らし、抗生物質耐性疾患の発生率を下げることができます。費用対効果が高く効率的な抗菌医療用テキスタイルに対する需要の高まりにより、市場は2024年から2031年にかけてCAGR 7.40%で成長します。

抗菌医療用テキスタイル市場定義/概要

抗菌医療用テキスタイルは、細菌、真菌、ウイルスなどの細菌の増殖を防ぐ素材です。これらのテキスタイルは、銀イオン、銅、亜鉛などの様々な抗菌剤を繊維や生地のコーティングに埋め込んで開発されます。抗菌医療用テキスタイルは、主に創傷被覆材、手術用ドレープ、個人用保護具（PPE）に使用されています。このような用途では、抗菌品質が感染を予防し、二次汚染のリスクを低減し、全体的な医療衛生を向上させる役割を果たします。また、これらの素材は病院の寝具やユニフォームにも使用され、患者やヘルスケア従事者双方にとって清潔で安全な環境を保っています。

抗菌医療用テキスタイルは有望であり、その効果を高め、用途を広げることを目的とした研究が続けられています。研究は、洗濯を繰り返しても抗菌特性が長持ちするテキスタイルを作ることや、様々な医療機器や治療法との適合性を向上させることを目的としています。

抗菌テキスタイルにセンサーや薬物送達システムなどのスマート技術を組み込んで、より集中的で応答性の高いヘルスケアソリューションを提供することへの関心が高まっています。感染制御と患者の安全に対する需要が高まるにつれ、抗菌医療用テキスタイルの市場は、材料科学の進歩とヘルスケア関連の感染に対する意識の高まりにより、拡大する可能性が高いです。

医療現場における衛生意識の高まりは、抗菌医療用テキスタイル市場をどのように牽引するか？

医療現場における衛生意識の高まりは、抗菌医療用テキスタイル市場に拍車をかけると予測されます。COVID-19の大流行により、感染管理に対する意識がかなり高まり、その結果、ヘルスケア環境における衛生がより重視されるようになりました。世界保健機関（WHO）は、手を十分に清潔にするだけで、医療関連感染を最大50％減少させることができるとしており、感染予防対策の必要性を強調しています。このように衛生面が重視されるようになったことで、安全性の向上と感染リスクの低減のために、スクラブやベッドリネンなどの抗菌性繊維の採用が急がれており、市場の成長を促進しています。

ヘルスケア関連感染症（HAI）の増加は、抗菌医療用テキスタイル市場の活性化につながると予測されます。米国疾病予防管理センター（CDC）の報告によると、病院患者の約31人に1人が1日に少なくとも1回のHAIを経験しており、感染症軽減ソリューションの需要が増加しています。抗菌医療用テキスタイルは、こうしたリスクを最小限に抑え、ヘルスケア環境の安全性を向上させるために不可欠であり、HAIの多発に取り組む施設にとってますます望ましいものとなっています。

原材料価格の高騰は抗菌医療用テキスタイル市場の成長をどのように阻害するか？

原材料価格の高騰は、抗菌医療用テキスタイル市場の成長を制限すると予測されています。これらの繊維の製造には、一般的に銀イオン、銅、その他の抗菌化合物のような高度な成分が含まれるため、高価になりやすいです。原材料費が高騰すれば全体的な製造コストも上昇し、ヘルスケア施設向けの抗菌医療用テキスタイルのコストが上昇します。このコスト負担は、特に予算が厳しい地域や施設での採用を制限し、市場拡大を遅らせる可能性があります。原材料価格の変動はメーカーに不確実性をもたらし、市場の拡大を制限する可能性があります。

抗菌医療用テキスタイルの弾力性と寿命は、市場拡大を制限する可能性があります。これらのテキスタイルは長持ちし、長期間にわたって抗菌特性を維持することを目的としているが、耐久性が向上することで交換頻度が減り、結果として需要が減少する可能性があります。高品質で長持ちする抗菌性テキスタイルに投資するヘルスケア施設では、新製品の購入需要が減少し、市場の成長が鈍化する可能性があります。耐久性のある繊維に関連する初期コストが高いため、特に費用対効果の高い短期的な解決策を求める一部の購入者が敬遠し、市場の進展が制限される可能性があります。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 抗菌医療用テキスタイル市場：テキスタイルタイプ別

• 手術用ドレープ
• 手術衣
• フェイスマスク
• 創傷被覆材

第5章 抗菌医療用テキスタイル市場：用途別

• 病院
• 診療所
• 外来手術センター

第6章 抗菌医療用テキスタイル市場：材料別

• ポリエステル
• ポリアミド
• ポリプロピレン
• 綿

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Johnson & Johnson Private Limited
• Ahlstrom
• DuPont
• 3M
• Techtex
• Medline Industries, Inc
• Dynarex Corporation
• Hakuzo Medical Asia Co
• Smith+Nephew

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Antimicrobial Medical Textiles Market Valuation - 2024-2031

The rising healthcare burden, as well as the growing emphasis on infection prevention and control, are driving up demand for antimicrobial medical textiles. As healthcare expenses rise, there is an increasing demand for effective and cost-effective solutions to reduce healthcare-associated infections (HAIs). Antimicrobial textiles are a viable strategy for preventing the spread of hazardous infections, improving patient outcomes, and lowering healthcare costs. The market size surpass USD 15.51 Billion valued in 2024 to reach a valuation of aroundUSD 26.07 Billion by 2031.

The growing frequency of antibiotic resistance poses a substantial threat to public health. Antimicrobial textiles can help address antibiotic resistance by providing an alternate method of infection control that does not use antibiotics. By adding antimicrobial qualities to medical textiles, healthcare institutions can provide a more sanitary atmosphere and reduce dependency on antibiotics, lowering the incidence of antibiotic-resistant illnesses. The rising demand for cost-effective and efficient antimicrobial medical textiles is enabling the market grow at aCAGR of 7.40% from 2024 to 2031.

Antimicrobial Medical Textiles Market: Definition/ Overview

Antimicrobial medical textiles are materials that prevent the growth of germs like bacteria, fungi, and viruses. These textiles are developed with various antimicrobial agents, such as silver ions, copper, or zinc, that are embedded into the fibers or coatings of the fabric. Antimicrobial medical textiles are primarily used for wound dressings, surgical drapes, and personal protective equipment (PPE). In these uses, antimicrobial qualities serve to prevent infections, reduce the risk of cross-contamination, and improve overall medical hygiene. These materials are also utilized in hospital bedding and uniforms to keep the atmosphere clean and safe for both patients and healthcare workers.

Antimicrobial medical textiles appear promising, with continuous research aiming at enhancing their effectiveness and broadening their applications. Research is aimed at creating textiles with longer-lasting antimicrobial characteristics, even after repeated washes, as well as improving their compatibility with various medical equipment and therapies.

There is a rising interest in incorporating smart technologies like sensors and medicine delivery systems into antimicrobial textiles to give more focused and responsive healthcare solutions. As the demand for infection control and patient safety grows, the market for antimicrobial medical textiles is likely to expand, owing to advances in materials science and growing awareness of healthcare-related infections.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How will the Growing Awareness of Hygiene in Medical Settings Drive the Antimicrobial Medical Textiles Market?

The increasing awareness of hygiene in medical settings is projected to fuel the antimicrobial medical textiles market. The COVID-19 pandemic has considerably increased awareness of infection management, resulting in a greater emphasis on hygiene in healthcare settings. The World Health Organization (WHO) states that adequate hand cleanliness alone can reduce healthcare-associated infections by up to 50%, emphasizing the necessity of infection prevention measures. This increased emphasis on hygiene is hastening the adoption of antimicrobial fabrics, such as scrubs and bed linens, to improve safety and lower the risk of infection, hence driving market growth.

The rising number of healthcare-associated infections (HAIs) is predicted to fuel the antimicrobial medical textiles market. With the Centers for Disease Control and Prevention (CDC) reporting that approximately one in every 31 hospital patients experiences at least one HAI on any given day, the demand for infection-mitigation solutions is increasing. Antimicrobial medical textiles are essential in minimizing these risks and improving safety in healthcare environments, making them increasingly desirable as facilities work to tackle the high occurrence of HAIs.

How Does the High Price of Raw Materials Hinder the Growth of the Antimicrobial Medical Textiles Market?

The high price of raw materials is projected to restrict the growth of the antimicrobial medical textiles market. The manufacture of these fabrics generally involves advanced ingredients like silver ions, copper, and other antibacterial compounds, which can be expensive. As raw material costs grow, so do overall production costs, increasing the cost of antimicrobial medical textiles for healthcare facilities. This cost burden may limit adoption, particularly in regions or institutions with tight budgets, delaying market expansion. Fluctuations in raw material prices can cause uncertainty for manufacturers, limiting the market's expansion.

The resilience and lifespan of antimicrobial medical textiles can limit market expansion. While these textiles are intended to be long-lasting and retain antibacterial characteristics over time, their increased durability may reduce the frequency of replacements, resulting in lesser demand. Healthcare facilities that invest in high-quality, long-lasting antimicrobial textiles may reduce the demand for new product purchases, thereby slowing market growth. The initial greater cost associated with durable fabrics may deter some purchasers, particularly those seeking more cost-effective, short-term solutions, limiting the market's progress.

Category-Wise Acumens

Will the Biocompatibility Fuel the Cotton Segment for the Antimicrobial Medical Textiles Market?

Cotton, a natural material, has long held the lead in the antimicrobial medical textiles market. Biocompatibility is expected to propel the cotton section of the antimicrobial medical textiles market. Cotton is a natural, hypoallergenic, and highly biocompatible material, making it ideal for use in medical settings where skin sensitivity and comfort are essential. Cotton's ability to be easily treated with antibacterial agents while maintaining its softness and breathability adds to its attractiveness. As healthcare professionals prioritize materials that are both effective and soft on the skin, demand for cotton-based antimicrobial textiles is likely to rise, boosting the market for this sector.

The risk of skin irritation and allergies may boost the expansion of the cotton segment in the antimicrobial medical textile market. Cotton is known for its natural softness, breathability, and hypoallergenic characteristics, which make it easier to cause skin irritation or allergic reactions than synthetic fibers. As healthcare professionals and patients become more aware of the necessity of skin-friendly materials, particularly in settings where extended contact with textiles is common, demand for cotton-based antimicrobial textiles is likely to rise. This emphasis on reducing skin irritation and allergies benefits the cotton portion of the market.

Will the Risk of Healthcare-Associated Infections (HAIs) Boost the Hospitals and Clinics Category in the Antimicrobial Medical Textiles Market?

Hospitals and clinics dominate the antimicrobial medical textiles market. The danger of healthcare-associated infections (HAIs) is expected to boost the hospital and clinic segment of the antimicrobial medical textiles market. HAIs are a substantial hazard in healthcare settings, causing longer hospital stays, higher medical expenses, and increased patient morbidity. To tackle these hazards, hospitals and clinics are increasingly using antimicrobial materials including bedding, uniforms, and surgical drapes to help prevent the spread of infections. As the emphasis on infection control grows, demand for these textiles in hospitals and clinics is likely to increase, boosting growth in this market segment.

The growing need to comply with stringent infection control requirements is expected to promote the use of antimicrobial fabrics in the hospital and clinic segment of the antimicrobial medical textiles market. Regulatory entities and healthcare organizations are implementing strict requirements to prevent healthcare-associated infections (HAIs) and increase patient safety. To achieve these standards, hospitals and clinics are turning to antimicrobial textiles, such as gowns, bed linens, and curtains, which are an efficient way to reduce infection risks. This regulatory pressure encourages healthcare facilities to invest in antimicrobial fabrics, fueling growth in this market segment.

Country/Region-wise Acumens

Will the Well-Developed Healthcare Infrastructure Encourage the North American Antimicrobial Medical Textiles Market?

North America leads the antimicrobial medical textiles market. North America's well-developed healthcare infrastructure is projected to drive the regional antimicrobial medical textiles market. As of 2022, the United States had 6,093 hospitals with 919,649 staffed beds, and the Centers for Medicare & Medicaid Services expects national health spending to increase at a 5.4% annual rate, reaching approximately USD 7.2 Trillion by 2031. A projected 13% increase in healthcare occupations, adding about 2 million new employments by 2031, will boost demand for antimicrobial fabrics.

High investment in medical technologies is propelling the antimicrobial medical textiles market in North America. The US medical technology market, valued at USD 176 Billion in 2022 and projected to increase at a 5% compound annual growth rate through 2025, has a strong financial commitment to innovation. Investment in digital health companies, which raised USD 29.1 Billion in 2021, and the National Institutes of Health's $45.1 billion research budget for fiscal year 2023 are speeding up the development of advanced medical technology, such as antimicrobial fabrics. This investment is vital in addressing the critical issue of healthcare-associated infections, which affect one out of every 31 hospital patients daily, according to the CDC. The convergence of significant financial backing and the requirement for enhanced infection control solutions is driving the expansion of the antimicrobial medical textiles market in North America.

Will the Rapid Economic Growth Accelerate the Asia-Pacific Region for the Antimicrobial Medical Textiles Market?

The Asia-Pacific region's antimicrobial medical textiles market is expanding rapidly. Rapid economic expansion in Asia-Pacific is propelling the antimicrobial medical textiles market. The regional economy is expected to grow by 4.8% in 2024 and is anticipated to reach 5.2%; thereby, resulting in considerable increase in healthcare spending. According to the World Health Organization (WHO), health spending in the Western Pacific Region has increased at an average yearly rate of 6.5%, significantly higher than the global average of 3.9%. China's healthcare spending is estimated to exceed USD 2.3 Trillion by 2030. This economic boom, combined with the high incidence of healthcare-associated infections (HAIs), which in some locations can reach 15.5 illnesses per 100 patients, is driving demand for sophisticated antimicrobial fabrics.

Cost-effective manufacturing is propelling the Asia-Pacific region's expansion in the antimicrobial medical textiles market. In 2022, Asia-Pacific accounted for 51.5% of global manufacturing value-added, with China accounting for 28.7%, and manufacturing labor costs in the region are much lower than in Western countries, with Vietnam paying $2.99 per hour vs $29.81 in the United States. This cost advantage attracts worldwide corporations, resulting in increasing textile manufacturing and exports, including innovative antimicrobial materials. The market for antimicrobial textiles is rapidly expanding, with projected spending on healthcare-acquired infection control reaching USD 3.2 Billion by 2025, owing to high rates of healthcare-associated infections (HAIs) in Southeast Asia, where prevalence can reach 15.5 per 100 patients.

Competitive Landscape

The antimicrobial medical textiles market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the antimicrobial medical textiles market include:

• Johnson & Johnson Private Limited
• Ahlstrom
• DuPont
• 3M
• Techtex
• Medline Industries, Inc.
• Dynarex Corporation
• Hakuzo Medical Asia Co
• Smith+Nephew

Latest Developments

• In October 2023, Sinanen Zeomic Co., Ltd., a firm that manufactures antimicrobial agents, teamed with Nordic BioTech Group Ltd. in South Korea and Japan for their NordShield series, which is a natural plant-based antimicrobial agent offered by Nordic BioTech Group.
• In March 2021, Mitsui & Co., Inc. renewed its distribution arrangement with PurThread Technologies, Inc. bringing the latter's proprietary permanent antimicrobial fibers and yarn soft products and textiles to its wide distribution networks and Japanese production facilities.
• In April 2020, Milliken announced textile manufacturing to produce innovative medical personal protective equipment for the medical industry amid the COVID-19 pandemic. The BioSmartTM antimicrobial technology was employed in lab coats, scrubs, and hospital curtains, killing up to 99.9% of common germs on contact.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Antimicrobial Medical Textiles Market, By Type of Textile

• Surgical drapes
• Surgical gowns
• Face masks
• Wound dressings

5. Antimicrobial Medical Textiles Market, By Application

• Hospitals
• Clinics
• Ambulatory Surgical Centers

6. Antimicrobial Medical Textiles Market, By Material

• Polyester
• Polyamide
• Polypropylene
• Cotton

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Johnson & Johnson Private Limited
• Ahlstrom
• DuPont
• 3M
• Techtex
• Medline Industries, Inc
• Dynarex Corporation
• Hakuzo Medical Asia Co
• Smith+Nephew

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References